A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants.
Yang Z, Wang Y, Jin Y, Zhu Y, Wu Y, Li C, Kong Y, Song W, Tian X, Zhan W, Huang A, Zhou S, Xia S, Tian X, Peng C, Chen C, Shi Y, Hu G, Du S, Wang Y, Xie Y, Jiang S, Lu L, Sun L, Song Y, Ying T.
Yang Z, et al. Among authors: huang a.
Signal Transduct Target Ther. 2021 Nov 3;6(1):378. doi: 10.1038/s41392-021-00810-1.
Signal Transduct Target Ther. 2021.
PMID: 34732694
Free PMC article.